| 1 |
35043423 | Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model. | 2022 Jul |
1 |
| 2 |
28257599 | Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. | 2017 Jul |
1 |
| 3 |
27367933 | The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®. | 2016 Oct |
1 |
| 4 |
25379560 | Flow cytometric evaluation of T cell activation markers after cardiopulmonary bypass. | 2014 |
2 |
| 5 |
22417245 | Downregulation of circulating CD4+ CD25(bright) Foxp3+ T cells by cyclosporine therapy and correlation with clinical response in psoriasis patients: report of three cases. | 2013 Nov |
1 |
| 6 |
22944461 | Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease. | 2012 Dec |
1 |
| 7 |
22094768 | Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. | 2011 Dec |
1 |
| 8 |
19903662 | Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs. | 2010 Mar |
4 |
| 9 |
20470309 | Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients. | 2010 Apr |
2 |
| 10 |
20595929 | The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression. | 2010 Sep 27 |
2 |
| 11 |
18424069 | Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis. | 2008 Jun |
2 |
| 12 |
18477227 | Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. | 2008 May |
1 |
| 13 |
18957170 | Polysaccharopeptide mimics ciclosporin-mediated Th1/Th2 cytokine balance for suppression of activated human T cell proliferation by MAPKp38 and STAT5 pathways. | 2008 Nov |
1 |
| 14 |
17227295 | Pharmacodynamics of T-cell function for monitoring immunosuppression. | 2007 Feb |
1 |
| 15 |
17493526 | Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade. | 2007 Jun |
1 |
| 16 |
17889153 | Do anti-CD25 monoclonal antibodies potentiate posttransplant diabetes mellitus? | 2007 Sep |
1 |
| 17 |
18021968 | The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. | 2007 Nov |
6 |
| 18 |
16126800 | An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab. | 2006 Apr |
1 |
| 19 |
15866683 | Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST). | 2005 Apr |
1 |
| 20 |
16182762 | Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation. | 2005 Jul-Aug |
1 |
| 21 |
16313313 | Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: a review. | 2005 Dec |
1 |
| 22 |
15041317 | Use of cyclosporine in renal transplantation. | 2004 Mar |
1 |
| 23 |
15282533 | Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. | 2004 Aug |
1 |
| 24 |
12773967 | New monoclonal antibodies in renal transplantation. | 2003 Mar |
3 |
| 25 |
12021552 | Tuning of T cell clone size and activation threshold by control of CD25 expression through mitogen-activated protein kinase pathways. | 2002 Apr |
1 |
| 26 |
12197897 | Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis. | 2002 Sep |
1 |
| 27 |
11438213 | Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes. | 2001 Jul |
1 |
| 28 |
11571448 | A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. | 2001 Sep 15 |
1 |
| 29 |
11604047 | Role of anti-interleukin-2 receptor antibodies in kidney transplantation. | 2001 |
1 |
| 30 |
11773888 | Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. | 2001 Dec 27 |
2 |
| 31 |
10729995 | Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia. | 2000 Jan |
1 |
| 32 |
10762208 | Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine. | 2000 Mar 27 |
2 |
| 33 |
10844492 | Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody. | 2000 May |
2 |
| 34 |
11073027 | Interleukin-2 receptor antibody-induced alterations of ciclosporin dose requirements in paediatric transplant recipients. | 2000 Oct 14 |
1 |
| 35 |
11145094 | [Daclizumab and basiliximab: monoclonal mouse-man antibodies with effective immunosuppression without side effects]. | 2000 Dec 9 |
1 |
| 36 |
9950598 | The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. | 1999 Feb |
1 |
| 37 |
10507492 | Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression. | 1999 Sep 15 |
2 |
| 38 |
10559581 | Effects of cyclosporin A on immune activation markers in patients with active psoriasis. | 1999 |
1 |
| 39 |
9245491 | Suppression of dialysis patients' lymphocyte IL-2R expression by glucocorticoids and cyclosporine. | 1997 Aug |
1 |
| 40 |
7570986 | Human vascular endothelial cells do not induce anergy in allogeneic CD4+ T cells unless costimulation is prevented. | 1995 Oct 15 |
1 |
| 41 |
8557519 | Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. | 1995 Sep |
5 |
| 42 |
7929104 | Regulation of interleukin-2 receptor alpha chain expression and nuclear factor.kappa B activation by protein kinase C in T lymphocytes. Autocrine role of tumor necrosis factor alpha. | 1994 Sep 30 |
2 |
| 43 |
8137548 | Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. | 1994 Mar |
2 |
| 44 |
8207202 | Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. | 1994 Jun 15 |
1 |
| 45 |
7511004 | Retinal antigen specific lymphocytes, TCR-gamma delta T cells and CD5+ B cells cultured from the vitreous in acute sympathetic ophthalmitis. | 1993 |
1 |
| 46 |
7678231 | Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506. | 1993 Jan |
1 |
| 47 |
8278994 | Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production. | 1993 Dec |
1 |
| 48 |
8500270 | In vivo and in vitro suppression of T-cell receptor alpha/beta CD4- CD8- T lymphocytes by cyclosporine A. | 1993 Jun |
1 |
| 49 |
1289145 | Immunocytochemical analysis of blood lymphocytes in uveitis. | 1992 |
1 |
| 50 |
1325148 | Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoring. | 1992 Jul |
2 |